220 followers
RT @AliceYYCheng: So far, 84% would offer SGLT2i to person living w/ #T1D under right circumstances. Study below reminds that person living…
RT @AliceYYCheng: So far, 84% would offer SGLT2i to person living w/ #T1D under right circumstances. Study below reminds that person living…
So far, 84% would offer SGLT2i to person living w/ #T1D under right circumstances. Study below reminds that person living w/#T1D i#willing to accept DKA risks depending on benefits. Low dose SGLT2i preferred by many! But will low dose give organ benefit…
RT @RosaCorcoy: En una encuesta, el tto combinado con dosis bajas de SGLTi fue la opción preferida por los pacientes con DM1 https://t.co/p…
RT @AliceYYCheng: Give the people what they want! Informed decisions made by the true experts in one’s health care - the person living it!…